Correlia Biosystems develops rapid and miniaturized proteomics tools to accelerate data-driven pharma research, clinical trials, and precision medicine. Our instruments, consumables, and software provide ultra-efficient measurement of biomarkers from drops of blood or biological sample using a simple platform for the lab or point-of-care.

Correlia’s ANDI gel technology enables multiplexed and quantitative immunoassays in 15 minutes with 2ul sample requirement. We currently seek cutting edge research groups to run pilots for PK/PD studies, biomarker analysis, longitudinal studies in individual mice, analysis of cell supernatants or lysates from micro-biopsies, retrospective studies from limited sample libraries, or other areas where rapid and efficient protein quantitation from miniaturized or precious samples is critical